GlassScriptPhysician profile
Linnea Gaus
NPI 1477620987
$425.83
in general payments reported to CMS, 2019-2025
8 companies · $62.46 in 2025
The $62.46 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.59 · 2023: $115 · 2024: $162 · 2025: $62.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $129.31 | 2021-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.75 | 2023-2024 | Lifevest |
| Procyrion, INC. | $52.55 | 2024 | |
| Novartis Pharmaceuticals Corporation | $46.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $39.30 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $36.24 | 2024 | Xarelto |
| Abiomed | $29.52 | 2023 | Impella |
| Scpharmaceuticals INC. | $23.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linnea Gaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.